EUVIMEDEUVIMED entdecken
Crossref

Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective

Jodi P Hansgen iD, Megan L Robertson iD, Ellen M Verzino iD, Lindsay M Manning iD

Journal of Pharmacy Practice · 2024

DOI: 10.1177/08971900241247598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Jodi P Hansgen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Services, Baylor Scott & White Health Plan, Temple, TX, USA. Hauptthemen laut MEDLINE: Naloxone, Analgesics, Opioid, Narcotic Antagonists, Managed Care Programs. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Opioid overdoses decrease when communities have access to naloxone. Clinicians play a key role in offering naloxone to high-risk chronic opioid patients. Managed care pharmacists within our health plan noted disproportionate processing for claims of opioid utilizers compared to claims of naloxone prescriptions.

Objective

To increase naloxone access and prescribing to members who classify at a dosage with a higher risk for opioid overdose, defined as over 90 morphine milligram equivalents (MME).

Methods

Multiple system-wide initiatives were implemented to improve naloxone access. A claims file was pulled monthly to identify members on opioids meeting MME criteria >90 MME per day excluding members with cancer, sickle cell disease, or on hospice. A separate report was then matched to naloxone claims and prescribing percentages calculated.

Results

12 444 utilizing members on opioids were identified from June 2019 prescription claims data. Of these, 131 were on opioids exceeding 90 MME per day, or 1.05% of utilizers, and the percentage of members exceeding 90 MME per day prescribed naloxone was 6.87%. By May 2023, the percentage of opioid utilizers exceeding 90 MME per day decreased to 0.58%. Naloxone prescribing increased to 41.18%.

Conclusion

A multi-pronged approach to improve access to naloxone and continued educational efforts by our health plan increased naloxone prescribing in members on opioids exceeding 90 MME per day.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaloxoneAnalgesics, OpioidNarcotic AntagonistsManaged Care ProgramsHumansPractice Patterns, Physicians'Health Services AccessibilityOpiate OverdoseMaleDrug PrescriptionsPharmaceutical ServicesOpioid-Related DisordersFemale

Stichwörter der Autor:innen

managed care organizationnaloxone accessnaloxone prescribingopioid overdose educationpharmacists

Substanzen

NaloxoneAnalgesics, OpioidNarcotic Antagonists

Autor:innen und Institutionen

  • Pharmacy Services, Baylor Scott & White Health Plan, Temple, TX, USA.

ORCID-Profile: Jodi P Hansgen, Megan L Robertson, Ellen M Verzino, Lindsay M Manning

Zitieren

APA

Hansgen, J. P., Robertson, M. L., Verzino, E. M., & Manning, L. M. (2024). Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241247598

Vancouver

Hansgen JP, Robertson ML, Verzino EM, Manning LM. Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900241247598

BibTeX
@article{Hansgen2024,
  author = {Hansgen, Jodi P and Robertson, Megan L and Verzino, Ellen M and Manning, Lindsay M},
  title = {Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective},
  journal = {Journal of Pharmacy Practice},
  year = {2024},
  doi = {10.1177/08971900241247598}
}
Kostenlos starten →